Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)

CAPS Rating: 3 out of 5

A development stage pharmaceutical company that seeks to acquire and develop innovative products for the treatment of a variety of human diseases.

Featured Broker Partners


Advertisement